• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Lupus Nephritis Caused by Systemic Lupus Erythematosus-- Developing Medical Products for Treatment

 

 

  • This guidance has been withdrawn. 
  • For further information regarding this topic, please contact Leila P. Hann (phone: 301-796-3367) in CDER; Philip Desjardins (phone: 301-796-5678) in CDRH; and/or Stephen Ripley (301-827-6210) in CBER.